BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 23992909)

  • 1. [Good glycaemic control can prevent diabetic peripheral neuropathy].
    Gregersen S
    Ugeskr Laeger; 2013 Sep; 175(36):2022-5. PubMed ID: 23992909
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enhanced glucose control for preventing and treating diabetic neuropathy.
    Callaghan BC; Little AA; Feldman EL; Hughes RA
    Cochrane Database Syst Rev; 2012 Jun; 6(6):CD007543. PubMed ID: 22696371
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of glycaemic variability evaluated by continuous glucose monitoring with diabetic peripheral neuropathy in type 2 diabetic patients.
    Hu YM; Zhao LH; Zhang XL; Cai HL; Huang HY; Xu F; Chen T; Wang XQ; Guo AS; Li JA; Su JB
    Endocrine; 2018 May; 60(2):292-300. PubMed ID: 29411305
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Switching to multiple daily injection therapy with glulisine improves glycaemic control, vascular damage and treatment satisfaction in basal insulin glargine-injected diabetic patients.
    Yanagisawa K; Ashihara J; Obara S; Wada N; Takeuchi M; Nishino Y; Maeda S; Ishibashi Y; Yamagishi S
    Diabetes Metab Res Rev; 2014 Nov; 30(8):693-700. PubMed ID: 24639403
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Burning through the pain: treatments for diabetic neuropathy.
    Javed S; Alam U; Malik RA
    Diabetes Obes Metab; 2015 Dec; 17(12):1115-25. PubMed ID: 26179288
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Near-normoglycaemia and development of neuropathy: a 24-year prospective study from diagnosis of type 1 diabetes.
    Ziegler D; Behler M; Schroers-Teuber M; Roden M
    BMJ Open; 2015 Jun; 5(6):e006559. PubMed ID: 26109108
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Continuous subcutaneous insulin infusion preserves axonal function in type 1 diabetes mellitus.
    Kwai N; Arnold R; Poynten AM; Lin CS; Kiernan MC; Krishnan AV
    Diabetes Metab Res Rev; 2015 Feb; 31(2):175-82. PubMed ID: 25066412
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intensive insulin regimens: evidence for benefit.
    Bretzel RG
    Int J Obes Relat Metab Disord; 2004 Sep; 28 Suppl 2():S8-13. PubMed ID: 15306832
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aldose reductase inhibitors in the treatment of diabetic peripheral neuropathy: a review.
    Schemmel KE; Padiyara RS; D'Souza JJ
    J Diabetes Complications; 2010; 24(5):354-60. PubMed ID: 19748287
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effects of improved glycemic control on complications in type 2 diabetes.
    Gaster B; Hirsch IB
    Arch Intern Med; 1998 Jan; 158(2):134-40. PubMed ID: 9448551
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Implications of the diabetes control and complications trial. American Diabetes Association.
    J Fla Med Assoc; 1998 Aug; 85(2):22-4. PubMed ID: 9782715
    [No Abstract]   [Full Text] [Related]  

  • 12. Managing diabetes: lessons from Type 1 diabetes mellitus.
    Cryer PE
    Diabet Med; 1998; 15 Suppl 4():S8-12. PubMed ID: 9868985
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An update on the long-acting insulin analogue glargine.
    Thisted H; Johnsen SP; Rungby J
    Basic Clin Pharmacol Toxicol; 2006 Jul; 99(1):1-11. PubMed ID: 16867163
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pathological mechanisms involved in diabetic neuropathy: can we slow the process?
    Sima AA
    Curr Opin Investig Drugs; 2006 Apr; 7(4):324-37. PubMed ID: 16625819
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relationship between peripheral diabetic neuropathy and microvascular reactivity in patients with type 1 and type 2 diabetes mellitus -- neuropathy and microcirculation in diabetes.
    Kasalová Z; Prázný M; Skrha J
    Exp Clin Endocrinol Diabetes; 2006 Feb; 114(2):52-7. PubMed ID: 16570233
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fasting hyperglycemia: etiology, diagnosis, and treatment.
    Sheehan JP
    Diabetes Technol Ther; 2004 Aug; 6(4):525-33. PubMed ID: 15321011
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of glycaemic control and the introduction of insulin therapy on retinopathy in non-insulin-dependent diabetes mellitus.
    Stratton IM; Matthews DR
    Diabet Med; 1997 Aug; 14(8):709-10. PubMed ID: 9272603
    [No Abstract]   [Full Text] [Related]  

  • 18. A study of autonomic neuropathy in diabetes mellitus in relation to its metabolic control.
    Gupta RC; Chittora MD; Jain A
    J Assoc Physicians India; 1995 Jul; 43(7):464-6. PubMed ID: 8713218
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diabetic neuropathy: effects of intensified glycaemic control with multiple insulin injections.
    Hotta N; Kawamori R; Sano T; Kakuta H; Kamada T; Sakamoto N
    Diabet Med; 1993; 10 Suppl 2():91S-94S. PubMed ID: 8334854
    [No Abstract]   [Full Text] [Related]  

  • 20. Mealtime glucose regulation in type 2 diabetes.
    Tuomilehto J; Del Prato S
    Int J Clin Pract; 2001; 55(6):380-3. PubMed ID: 11501227
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.